The Israeli Institute of Biological research has announced that it is expecting to start testing its potential COVID-19 vaccine on humans in October

After Jerusalem signed binding term sheet for purchase of drug, CEO of Arcturus Therapeutics says Phase 3 study needs to be held in location with substantial number of cases

TV reports country to buy four million units of drug made by Arcturus Therapeutics and Singapore's Duke-NUS medical school, recently granted permission to begin clinical trails

Jerusalem's Gamida Cell says 'lifesaving' stem-cell therapy helps increase success of bone marrow transplants; firm hopes to launch treatment in US in second half of 2021

Health Ministry opens pilot program after study shows effectiveness of MDMA in treating post trauma, common among IDF veterans

Pages